150840 — IntroMedic Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for IntroMedic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-19,320	-7,375	-13,860	-23,336	-6,865
Depreciation
Amortisation
Non-Cash Items	16,735	2,544	9,509	20,426	2,754
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,240	61.5	-331	-2,681	272
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2,922	-4,030	-3,627	-4,836	-3,323
Capital Expenditures	-2,659	-85.9	-493	-620	-963
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-12,954	-1,301	-13,854	9,542	2,038
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-15,612	-1,387	-14,347	8,922	1,075
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	16,239	8,380	17,981	-730	-4,813
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,295	2,963	6.4	3,260	-7,063